Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Evaluation of the Expanded Disability Status Scale and the Multiple Sclerosis Functional Composite as clinical endpoints in multiple sclerosis clinical trials: quantitative meta-analyses.
Corrigendum to "An investigation into the association between HLA-G 14bp insertion/deletion polymorphism and multiple sclerosis susceptibility" [Journal of Neuroimmunology 290 (2016) 115-118].
Strength of ERK1/2 MAPK Activation Determines Its Effect on Myelin and Axonal Integrity in the Adult CNS.
FOXP3(+) Treg Cells and Gender Bias in Autoimmune Diseases.
Proton-gated Ca(2+)-permeable TRP channels damage myelin in conditions mimicking ischaemia.
Ex vivo expanded regulatory T cells CD4(+)CD25(+)FoxP3(+)CD127(Low) develop strong immunosuppressive activity in patients with remitting-relapsing multiple sclerosis.
Liver X receptors: from cholesterol regulation to neuroprotection-a new barrier against neurodegeneration in amyotrophic lateral sclerosis?
Intravital assessment of myelin molecular order with polarimetric multiphoton microscopy.
Immunopathophysiology of pediatric CNS inflammatory demyelinating diseases.
Drugs for multiple sclerosis.
Vitamin D Status Does Not Affect Disability Progression of Patients with Multiple Sclerosis over Three Year Follow-Up.
Preparation of purified perikaryal and synaptosomal mitochondrial fractions from relatively small hypothalamic brain samples.
Altered Expression of Specific Transcription Factors of Th17 (RORγt, RORα) and Treg Lymphocytes (FOXP3) by Peripheral Blood Mononuclear Cells from Patients with Multiple Sclerosis.
Assessment of brain metabolite correlates of AAV-mediated overexpression of human alpha-synuclein in cortical neurons by in vivo(1) H-MR spectroscopy at 9.4 T.
The Costimulatory Receptor OX40 Inhibits Interleukin-17 Expression through Activation of Repressive Chromatin Remodeling Pathways.
Online Social Support for Patients with Multiple Sclerosis: A Thematic Analysis of Messages Posted to a Virtual Support Community.
Multiple sclerosis.
History of multiple sclerosis in 2 successive pregnancies: A French and Italian cohort.
The utility and accuracy of four equations in predicting sodium levels in dysnatremic patients.
Mendelian randomization shows a causal effect of low vitamin D on multiple sclerosis risk.
Vibration training improves disability status in multiple sclerosis: A pretest-posttest pilot study.
Progression of alpha-synuclein pathology in multiple system atrophy of the cerebellar type.
Inadequate outcome measures are the biggest impediment to successful clinical trials in progressive MS - YES.
Alemtuzumab improves preexisting disability in active relapsing-remitting MS patients.
Fumarate modulates the immune/inflammatory response and rescues nerve cells and neurological function after stroke in rats.
Pages
« first
‹ previous
…
805
806
807
808
809
810
811
812
813
…
next ›
last »